Nail lichen planus treatment safety

References

• Gupta MK, Lipner SR. Review of nail lichen planus: epidemiology, pathogenesis, diagnosis, and treatment. Dermatol Clin. 2021 Apr;39(2):221–230. doi: 10.1016/j.det.2020.12.002
   PubMed Web of Science ®Google Scholar
• Iorizzo M, Tosti A, Starace M, et al. Isolated nail lichen planus: an expert consensus on treatment of the classical form. J Am Acad Dermatol. 2020 Dec;83(6):1717–1723. doi: 10.1016/j.jaad.2020.02.056
   PubMed Web of Science ®Google Scholar
• Dehesa L, Tosti A. Treatment of inflammatory nail disorders. Dermatol Ther. 2012 Nov;25(6):525–534. doi: 10.1111/j.1529-8019.2012.01516.x
   PubMed Web of Science ®Google Scholar
• Lipner SR. Nail lichen planus: a true nail emergency. J Am Acad Dermatol. 2019 Jun;80(6):e177–e178. doi: 10.1016/j.jaad.2018.11.065
   PubMed Web of Science ®Google Scholar
• Olsen EA, Cornell RC. Topical clobetasol-17-propionate: review of its clinical efficacy and safety. J Am Acad Dermatol. 1986 Aug;15(2 Pt 1):246–255. doi: 10.1016/S0190-9622(86)70164-3
   PubMed Web of Science ®Google Scholar
• Park HJ, Gwak MJ, Jeong KH, et al. Incidence of topical tacrolimus adverse effects in chronic skin disease. Ann Dermatol. 2019 Feb;31(1):90–92. doi: 10.5021/ad.2019.31.1.90
   PubMed Web of Science ®Google Scholar
• Tham EH. Unboxing the black box on topical calcineurin inhibitors and cancer risk. Lancet Child Adolesc Health. 2023 Jan;7(1):2–3. doi: 10.1016/S2352-4642(22)00311-X
   PubMedGoogle Scholar
• Pai SB, Shetty S. Guidelines for bath PUVA, bathing suit PUVA and soak PUVA. Indian J Dermatol Venereol Leprol. 2015 Nov;81(6):559–567. doi: 10.4103/0378-6323.168336
   PubMed Web of Science ®Google Scholar
• da Veiga G P, Pérez-Feal P, Moreiras-Arias N, et al. Treatment of nail lichen planus with localized bath-PUVA. Photodermatol Photoimmunol Photomed. 2020 May;36(3):241–243. doi: 10.1111/phpp.12528
   PubMed Web of Science ®Google Scholar
• Grover C, Bansal S, Nanda S, et al. Efficacy of triamcinolone acetonide in various acquired nail dystrophies. J Dermatol. 2005 Dec;32(12):963–968. doi: 10.1111/j.1346-8138.2005.tb00882.x
   PubMed Web of Science ®Google Scholar
• Piraccini BM, Saccani E, Starace M, et al. Nail lichen planus: response to treatment and long term follow-up. Eur J Dermatol. 2010 Jul;20(4):489–496. doi: 10.1684/ejd.2010.0952
   PubMed Web of Science ®Google Scholar
• Tosti A, Peluso AM, Fanti PA, et al. Nail lichen planus: clinical and pathologic study of twenty-four patients. J Am Acad Dermatol. 1993 May;28(5 Pt 1):724–730. doi: 10.1016/0190-9622(93)70100-8
   PubMed Web of Science ®Google Scholar
• Alsenaid A, Eder I, Ruzicka T, et al. Successful treatment of nail lichen planus with alitretinoin: report of 2 cases and review of the literature. Dermatology. 2014;229(4):293–296. doi: 10.1159/000365655
   PubMed Web of Science ®Google Scholar
• Iorizzo M. Nail lichen planus - a possible new indication for oral alitretinoin. J Eur Acad Dermatol Venereol. 2016 Mar;30(3):509–510. doi: 10.1111/jdv.12904
   PubMed Web of Science ®Google Scholar
• King T, McKenna J, Alexandroff AB. Alitretinoin for the treatment of severe chronic hand eczema. Patient Prefer Adherence. 2014;8:1629–1634. doi: 10.2147/PPA.S38830
   PubMed Web of Science ®Google Scholar
• Napolitano M, Potestio L, De Lucia M, et al. Alitretinoin for the treatment of severe chronic eczema of the hands. Expert Opin Pharmacother. 2022 Feb;23(2):159–167. doi: 10.1080/14656566.2021.1998457
   PubMed Web of Science ®Google Scholar
• Samuel C, Cornman H, Kambala A, et al. A review on the safety of using JAK inhibitors in dermatology: clinical and laboratory monitoring. Dermatol Ther. 2023 Mar;13(3):729–749. doi: 10.1007/s13555-023-00892-5
   Web of Science ®Google Scholar
• Reich K, Gooderham M, Green L, et al. The efficacy and safety of apremilast, etanercept and placebo in patients with moderate-to-severe plaque psoriasis: 52-week results from a phase IIIb, randomized, placebo-controlled trial (LIBERATE). J Eur Acad Dermatol Venereol. 2017 Mar;31(3):507–517. doi: 10.1111/jdv.14015
   PubMed Web of Science ®Google Scholar
• Florian B, Angelika J, Ernst SR. Successful treatment of palmoplantar nail lichen planus with cyclosporine. J Dtsch Dermatol Ges. 2014 Aug;12(8):724–725. doi: 10.1111/ddg.12325
   PubMed Web of Science ®Google Scholar
• Ryan C, Amor KT, Menter A. The use of cyclosporine in dermatology: part II. J Am Acad Dermatol. 2010 Dec;63(6):949-72; quiz 973–4. doi: 10.1016/j.jaad.2010.02.062
   Google Scholar
• Nousari HC, Sragovich A, Kimyai-Asadi A, et al. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):265–268. doi: 10.1016/S0190-9622(99)70203-3
   PubMed Web of Science ®Google Scholar
• Park H. The emergence of mycophenolate mofetilin dermatology: from its roots in the world of organ transplantation to its versatile role in the dermatology treatment room. J Clin Aesthet Dermatol. 2011 Jan;4(1):18–27.
   PubMedGoogle Scholar
• Wei ZX, Tang TT, Jiang SP. The antiviral mechanisms, effects, safety and adverse effects of chloroquine. Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):7164–7172. doi: 10.26355/eurrev_202006_21712
   PubMed Web of Science ®Google Scholar
• Marmor MF, Kellner U, Lai TY, et al. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmol. 2016 Jun;123(6):1386–1394. doi: 10.1016/j.ophtha.2016.01.058
   PubMed Web of Science ®Google Scholar
• Goel P, Gerriets V. Chloroquine. StatPearls. Treasure island (FL) ineligible companies. Disclosure: Valerie Gerriets declares no relevant financial relationships with ineligible companies. StatPearls Publishing copyright 2023. Treasure Island, Florida, USA: StatPearls Publishing LLC; 2023.
   Google Scholar
• Ujiie H, Shibaki A, Akiyama M, et al. Successful treatment of nail lichen planus with topical tacrolimus. Acta Derm Venereol. 2010 Mar;90(2):218–219. doi: 10.2340/00015555-0814
   PubMed Web of Science ®Google Scholar
• British photodermatology group guidelines for PUVA. Br J Dermatol. 1994 Feb;130(2):246–255. doi: 10.1111/j.1365-2133.1994.tb02910.x
   PubMed Web of Science ®Google Scholar
• Kaiser FE, Doe RP. Steroid use in the elderly. Guidelines for avoiding adverse effects. Postgrad Med. 1984 Jul;76(1):65-8, 72–4. doi: 10.1080/00325481.1984.11698664
   Web of Science ®Google Scholar
• Jo M, Kang HS, Kim MS, et al. Efficacy and safety of Alitretinoin therapy in Korean elderly patients with chronic hand eczema: a retrospective single center study. Ann Dermatol. 2019 Dec;31(6):595–600. doi: 10.5021/ad.2019.31.6.595
   PubMed Web of Science ®Google Scholar
• Nogueira M, Paller AS, Torres T. Targeted therapy for pediatric psoriasis. Paediatr Drugs. 2021 May;23(3):203–212. doi: 10.1007/s40272-021-00443-5
   PubMed Web of Science ®Google Scholar
• Diotallevi F, Simonetti O, Rizzetto G, et al. Biological treatments for pediatric psoriasis: state of the art and future perspectives. Int J Mol Sci. 2022 Sep 22;23(19):11128. doi: 10.3390/ijms231911128
   PubMed Web of Science ®Google Scholar
• Lee JY. Severe 20-nail psoriasis successfully treated by low dose methotrexate. Dermatol Online J. 2009 Nov 15;15(11):8. doi: 10.5070/D32XF4V4PW
   Google Scholar
• Teran CG, Teran-Escalera CN, Balderrama C. A severe case of erythrodermic psoriasis associated with advanced nail and joint manifestations: a case report. J Med Case Rep. 2010 Jun 15;4(1):179. doi: 10.1186/1752-1947-4-179
   PubMedGoogle Scholar
• Paller AS, Seyger MMB, Magariños GA, et al. Long-term efficacy and safety of up to 108 weeks of ixekizumab in pediatric patients with moderate to severe plaque psoriasis: the IXORA-PEDS randomized clinical trial. JAMA Dermatol. 2022 May 1;158(5):533–541. doi: 10.1001/jamadermatol.2022.0655
   PubMed Web of Science ®Google Scholar
• Nash P, Mease PJ, Kirkham B, et al. Secukinumab provides sustained improvement in nail psoriasis, signs and symptoms of psoriatic arthritis and low rate of radiographic progression in patients with concomitant nail involvement: 2-year results from the phase III FUTURE 5 study. Clin Exp Rheumatol. 2022 May;40(5):952–959. doi: 10.55563/clinexprheumatol/3nuz51
   PubMed Web of Science ®Google Scholar
• Wells LE, Evans T, Hilton R, et al. Use of secukinumab in a pediatric patient leads to significant improvement in nail psoriasis and psoriatic arthritis. Pediatr Dermatol. 2019 May;36(3):384–385. doi: 10.1111/pde.13767
   PubMed Web of Science ®Google Scholar
• Watabe D, Endoh K, Maeda F, et al. Childhood-onset psoriatic onycho-pachydermo-periostitis treated successfully with infliximab. Eur J Dermatol. 2015 Sep;25(5):506–508. doi: 10.1684/ejd.2015.2616
   PubMed Web of Science ®Google Scholar
• Pereira TM, Vieira AP, Fernandes JC, et al. Anti-TNF-alpha therapy in childhood pustular psoriasis. Dermatology. 2006;213(4):350–352. doi: 10.1159/000096202
   PubMed Web of Science ®Google Scholar
• Migliore A, Bizzi E, Laganà B, et al. The safety of anti-TNF agents in the elderly. Int J Immunopathol Pharmacol. 2009 Apr;22(2):415–426. doi: 10.1177/039463200902200218
   PubMed Web of Science ®Google Scholar
• Rajasimhan S, Pamuk O, Katz JD. Safety of janus kinase inhibitors in older patients: a focus on the thromboembolic risk. Drugs Aging. 2020 Aug;37(8):551–558. doi: 10.1007/s40266-020-00775-w
   PubMed Web of Science ®Google Scholar
• Kovarik JM, Koelle EU. Cyclosporin pharmacokinetics in the elderly. Drugs Aging. 1999 Sep;15(3):197–205. doi: 10.2165/00002512-199915030-00003
   PubMed Web of Science ®Google Scholar
• Witek S, Malat G, Sawinski D, et al. Tolerability of mycophenolate mofetil in elderly kidney transplant recipients: a retrospective cohort study. Clin Transplant. 2022 Jul;36(7):e14671. doi: 10.1111/ctr.14671
   PubMed Web of Science ®Google Scholar
• Chi CC, Kirtschig G, Aberer W, et al. Evidence-based (S3) guideline on topical corticosteroids in pregnancy. Br J Dermatol. 2011 Nov;165(5):943–952. doi: 10.1111/j.1365-2133.2011.10513.x
   PubMed Web of Science ®Google Scholar
• Chi CC, Wang SH, Mayon-White R, et al. Pregnancy outcomes after maternal exposure to topical corticosteroids: a UK population-based cohort study. JAMA Dermatol. 2013 Nov;149(11):1274–1280. doi: 10.1001/jamadermatol.2013.5768
   PubMed Web of Science ®Google Scholar
• De Simone C, Maiorino A, Tassone F, et al. Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study. J Eur Acad Dermatol Venereol. 2013 Aug;27(8):1003–1006. doi: 10.1111/j.1468-3083.2012.04642.x
   PubMed Web of Science ®Google Scholar
• Weatherhead S, Robson SC, Reynolds NJ. Eczema in pregnancy. BMJ. 2007 Jul 21;335(7611):152–154. doi: 10.1136/bmj.39227.671227.AE
   PubMedGoogle Scholar
• Calzavara-Pinton PG, Ortel B, Hönigsmann H, et al. Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis. Dermatology. 1994;189(3):256–259. doi: 10.1159/000246849
   PubMed Web of Science ®Google Scholar
• Halpern SM, Anstey AV, Dawe RS, et al. Guidelines for topical PUVA: a report of a workshop of the British photodermatology group. Br J Dermatol. 2000 Jan;142(1):22–31. doi: 10.1046/j.1365-2133.2000.03237.x
   PubMed Web of Science ®Google Scholar
• Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007 Jul 21;370(9583):263–271. doi: 10.1016/S0140-6736(07)61128-3
   PubMed Web of Science ®Google Scholar
• Iorizzo M, Gioia Di Chiacchio N, Di Chiacchio N, et al. Intralesional steroid injections for inflammatory nail dystrophies in the pediatric population. Pediatr Dermatol. 2023 Mar;2020(4):759–761. doi: 10.1111/pde.15295
   Google Scholar
• Verbov J. The place of intralesional steroid therapy in dermatology. Br J Dermatol. 1976 Mar;94(suppl 12):51–58. doi: 10.1111/j.1365-2133.1976.tb02269.x
   PubMedGoogle Scholar
• Grover C, Kharghoria G, Daulatabad D, et al. Nicolau syndrome following intramatricial triamcinolone injection for nail lichen planus. Indian Dermatol Online J. 2017 Sep;8(5):350–351. doi: 10.4103/idoj.IDOJ_333_16
   PubMedGoogle Scholar
• Ricardo JW, Lipner SR. Recommendations for treatment of nail lichen planus during the COVID-19 pandemic. Dermatol Ther. 2020 Jul;33(4):e13551. doi: 10.1111/dth.13551
   PubMed Web of Science ®Google Scholar
• Goettmann S, Zaraa I, Moulonguet I. Nail lichen planus: epidemiological, clinical, pathological, therapeutic and prognosis study of 67 cases. J Eur Acad Dermatol Venereol. 2012 Oct;26(10):1304–1309. doi: 10.1111/j.1468-3083.2011.04288.x
   PubMed Web of Science ®Google Scholar
• Tosti A, Piraccini BM, Cambiaghi S, et al. Nail lichen planus in children: clinical features, response to treatment, and long-term follow-up. Arch Dermatol. 2001 Aug;137(8):1027–1032.
   PubMedGoogle Scholar
• Evans AV, Roest MA, Fletcher CL, et al. Isolated lichen planus of the toe nails treated with oral prednisolone. Clin Exp Dermatol. 2001 Jul;26(5):412–414. doi: 10.1046/j.1365-2230.2001.00848.x
   PubMed Web of Science ®Google Scholar
• Takeuchi Y, Iwase N, Suzuki M, et al. Lichen planus with involvement of all twenty nails and the oral mucous membrane. J Dermatol. 2000 Feb;27(2):94–98. doi: 10.1111/j.1346-8138.2000.tb02128.x
   PubMedGoogle Scholar
• Tziotzios C, Lee JYW, Brier T, et al. Lichen planus and lichenoid dermatoses: clinical overview and molecular basis. J Am Acad Dermatol. 2018 Nov;79(5):789–804. doi: 10.1016/j.jaad.2018.02.010
   PubMed Web of Science ®Google Scholar
• Blair HA, Scott LJ. Alitretinoin: a review in severe chronic hand eczema. Drugs. 2016 Sep;76(13):1271–1279. doi: 10.1007/s40265-016-0621-0
   PubMed Web of Science ®Google Scholar
• Ruzicka T, Larsen FG, Galewicz D, et al. Oral Alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, Double-blind, placebo-controlled, multicenter trial. Arch Dermatol. 2004;140(12):1453–1459. doi: 10.1001/archderm.140.12.1453
   PubMedGoogle Scholar
• Padda IS, Bhatt R, Parmar M. Tofacitinib. StartPearls. Treasure island (FL) ineligible companies. Disclosure: Rajat Bhatt declares no relevant financial relationships with ineligible companies. Disclosure: Mayur Parmar declares no relevant financial relationships with ineligible companies. StatPearls Publishing copyright 2023. Treasure Island, Florida: StatPearls Publishing LLC; 2023.
   Google Scholar
• Iorizzo M, Haneke E. Tofacitinib as treatment for nail lichen planus associated with Alopecia Universalis. JAMA Dermatol. 2021 Mar 1;157(3):352–353. doi: 10.1001/jamadermatol.2020.4555
   PubMed Web of Science ®Google Scholar
• Pünchera J, Laffitte E. Treatment of severe nail lichen planus with Baricitinib. JAMA Dermatol. 2022 Jan 1;158(1):107–108. doi: 10.1001/jamadermatol.2021.5082
   PubMed Web of Science ®Google Scholar
• Elmariah SB, Smith JS, Merola JF. JAK in the [black] box: a dermatology perspective on systemic JAK inhibitor safety. Am J Clin Dermatol. 2022 Jul;23(4):427–431. doi: 10.1007/s40257-022-00701-3
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Chaparro M. Safety of New biologics (vedolizumab and ustekinumab) and small molecules (Tofacitinib) during pregnancy: a review. Drugs. 2020 Jul;80(11):1085–1100. doi: 10.1007/s40265-020-01346-4
   PubMed Web of Science ®Google Scholar
• Irla N, Schneiter T, Haneke E, et al. Nail lichen planus: successful treatment with etanercept. Case Rep Dermatol. 2010 Oct 21;2(3):173–176. doi: 10.1159/000321419
   PubMedGoogle Scholar
• Kamata M, Tada Y. Safety of biologics in psoriasis. J Dermatol. 2018 Mar;45(3):279–286. doi: 10.1111/1346-8138.14096
   PubMed Web of Science ®Google Scholar
• Semble AL, Davis SA, Feldman SR. Safety and tolerability of tumor necrosis factor-α inhibitors in psoriasis: a narrative review. Am J Clin Dermatol. 2014 Feb;15(1):37–43. doi: 10.1007/s40257-013-0053-5
   PubMed Web of Science ®Google Scholar
• Raval G, Mehta P. TNF-α inhibitors: are they carcinogenic? Drug Healthc Patient Saf. 2010;2:241–247. doi: 10.2147/DHPS.S7829
   PubMedGoogle Scholar
• Mahadevan U, Long MD, Kane SV, et al. Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease. Gastroenterology. 2021 Mar;160(4):1131–1139. doi: 10.1053/j.gastro.2020.11.038
   PubMed Web of Science ®Google Scholar
• Ghalandari N, Dolhain R, Hazes JMW, et al. Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review. Drugs. 2020 Nov;80(16):1699–1722. doi: 10.1007/s40265-020-01376-y
   PubMed Web of Science ®Google Scholar
• De Felice KM, Kane S. Safety of anti-TNF agents in pregnancy. J Allergy Clin Immunol. 2021 Sep;148(3):661–667. doi: 10.1016/j.jaci.2021.07.005
   PubMed Web of Science ®Google Scholar
• Amor KT, Ryan C, Menter A. The use of cyclosporine in dermatology: part I. J Am Acad Dermatol. 2010 Dec;63(6):925-46; quiz 947–8. doi: 10.1016/j.jaad.2010.02.063
   Google Scholar
• Colombo MD, Cassano N, Bellia G, et al. Cyclosporine regimens in plaque psoriasis: an overview with special emphasis on dose, duration, and old and new treatment approaches. ScientificWorldjournal. 2013;2013:805705. doi: 10.1155/2013/805705
   PubMed Web of Science ®Google Scholar
• Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009 Sep;61(3):451–485. doi: 10.1016/j.jaad.2009.03.027
   PubMed Web of Science ®Google Scholar
• Orvis AK, Wesson SK, Breza TS Jr., et al. Mycophenolate mofetil in dermatology. J Am Acad Dermatol. 2009 Feb;60(2):183–199. quiz 200-2. doi: 10.1016/j.jaad.2008.08.049.
   PubMed Web of Science ®Google Scholar
• Duplaine A, Cogrel O. Mycophenolate mofetil in the treatment of severe corticosteroid-dependent or corticosteroid-resistant nail lichen planus: a case series of 5 patients. Skin Appendage Disord. 2022 Sep;8(5):427–430. doi: 10.1159/000524246
   PubMedGoogle Scholar
• Tendron A, Gouyon JB, Decramer S. In utero exposure to immunosuppressive drugs: experimental and clinical studies. Pediatr Nephrol. 2002 Feb;17(2):121–130. doi: 10.1007/s00467-001-0776-z
   PubMed Web of Science ®Google Scholar
• Sifontis NM, Coscia LA, Constantinescu S, et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation. 2006 Dec 27;82(12):1698–1702. doi: 10.1097/01.tp.0000252683.74584.29
   PubMed Web of Science ®Google Scholar
• Mostafa WZ. Lichen planus of the nail: treatment with antimalarials. J Am Acad Dermatol. 1989 Feb;20(2 Pt 1):289–290. doi: 10.1016/S0190-9622(89)80060-X
   PubMed Web of Science ®Google Scholar
• Wolfe MS, Cordero JF. Safety of chloroquine in chemosuppression of malaria during pregnancy. Br Med J (Clin Res Ed). 1985 May 18;290(6480):1466–1467. doi: 10.1136/bmj.290.6480.1466
   PubMedGoogle Scholar
• McGready R, Thwai KL, Cho T, et al. The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy. Trans R Soc Trop Med Hyg. 2002 Mar;96(2):180–184. doi: 10.1016/S0035-9203(02)90297-X
   PubMed Web of Science ®Google Scholar
• Kayentao K, Kodio M, Newman RD, et al. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. J Infect Dis. 2005 Jan 1;191(1):109–116. doi: 10.1086/426400
   PubMed Web of Science ®Google Scholar
• Lacroix I, Bénévent J, Damase-Michel C. Chloroquine and hydroxychloroquine during pregnancy: what do we know? Therapie. 2020 Jul;75(4):384–385. doi: 10.1016/j.therap.2020.05.004
   PubMed Web of Science ®Google Scholar
• Hodgens A, Sharman T. Corticosteroids. StatPearls. Treasure island (FL) ineligible companies. Disclosure: tariq Sharman declares no relevant financial relationships with ineligible companies.StatPearls Publishing copyright 2023. Treasure Island, Florida: StatPearls Publishing LLC; 2023.
   Google Scholar
• Motamed-Sanaye A, Khazaee YF, Shokrgozar M, et al. JAK inhibitors in lichen planus: a review of pathogenesis and treatments. J DermatolTreat. 2022 Dec;33(8):3098–3103. doi: 10.1080/09546634.2022.2116926
   Google Scholar
• Abduelmula A, Bagit A, Mufti A, et al. The use of janus kinase inhibitors for lichen planus: an evidence-based review. J Cutan Med Surg. 2023 May;27(3):271–276. doi: 10.1177/12034754231156100
   PubMed Web of Science ®Google Scholar
• Tegtmeyer K, Ravi M, Zhao J, et al. Off-label studies on the use of ruxolitinib in dermatology. Dermatitis. 2021 May 1;32(3):164–172. doi: 10.1097/DER.0000000000000658
   PubMed Web of Science ®Google Scholar
• White C, Miller R. A literature review investigating the use of topical janus kinase inhibitors for the treatment of vitiligo. J Clin Aesthet Dermatol. 2022 Apr;15(4):20–25.
   PubMedGoogle Scholar
• Solimani F, Pollmann R, Schmidt T, et al. Therapeutic targeting of Th17/Tc17 cells leads to clinical improvement of lichen planus. Front Immunol. 2019;10:1808. doi: 10.3389/fimmu.2019.01808
   PubMed Web of Science ®Google Scholar
• Thyssen JP, Vester L, Grønhøj Larsen C, et al. The single-dose pharmacokinetics of alitretinoin and its metabolites are not significantly altered in patients with cirrhosis. Br J Dermatol. 2014 Feb;170(2):408–414. doi: 10.1111/bjd.12546
   PubMed Web of Science ®Google Scholar
• Bubna AK. Alitretinoin in Dermatology-An Update. Indian J Dermatol. 2015 Sep;60(5):520. doi: 10.4103/0019-5154.164426
   PubMed Web of Science ®Google Scholar
• Kapila N, Gonzalez A, Rosado JM, et al. Safety of anti-TNF agents in patients with compensated cirrhosis: a case-control study. Therap Adv Gastroenterol. 2021;14:17562848211037094. doi: 10.1177/17562848211037094
   Web of Science ®Google Scholar
• Srinivas N, Barbour AM, Epstein N, et al. The effect of renal impairment on the pharmacokinetics and safety of Itacitinib. J Clin Pharmacol. 2020 Aug;60(8):1022–1029. doi: 10.1002/jcph.1601
   PubMed Web of Science ®Google Scholar
• Pietruck F, Budde K, Salvadori M, et al. Efficacy and safety of enteric-coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials. Clin Transplant. 2007 Jan;21(1):117–125. doi: 10.1111/j.1399-0012.2006.00615.x
   PubMed Web of Science ®Google Scholar
• Haubitz M, de Groot K. Tolerance of mycophenolate mofetil in end-stage renal disease patients with ANCA-associated vasculitis. Clin Nephrol. 2002 Jun;57(6):421–424. doi: 10.5414/CNP57421
   PubMed Web of Science ®Google Scholar
• Chloroquine. LiverTox: clinical and research information on drug-induced liver injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012.
   Google Scholar